34
IRUS TotalDownloads
Altmetric
Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0.
File | Description | Size | Format | |
---|---|---|---|---|
Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons vers.pdf | Published version | 103.84 kB | Adobe PDF | View/Open |
Title: | Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0. |
Authors: | Ryom, L Boesecke, C Bracchi, M Ambrosioni, J Pozniak, A Arribas, J Behrens, G Mallon, P Puoti, M Rauch, A Miro, JM Kirk, O Marzolini, C Lundgren, JD Battegay, M EACS Governing Board |
Item Type: | Journal Article |
Abstract: | BACKGROUND: The European AIDS Clinical Society (EACS) Guidelines have since 2005 provided multidisciplinary recommendations for the care of HIV-positive persons in geographically diverse areas. GUIDELINE HIGHLIGHTS: Major revisions have been made in all sections of the 2017 Guidelines: antiretroviral treatment (ART), comorbidities, coinfections and opportunistic diseases. Newly added are also a summary of the main changes made, and direct video links to the EACS online course on HIV Management. Recommendations on the clinical situations in which tenofovir alafenamide may be considered over tenofovir disoproxil fumarate are provided, and recommendations on which antiretrovirals can be used safely during pregnancy have been revised. Renal and bone toxicity and hepatitis C virus (HCV) treatment have been added as potential reasons for ART switches in fully virologically suppressed individuals, and dolutegravir/rilpivirine has been included as a treatment option. In contrast, dolutegravir monotherapy is not recommended. New recommendations on non-alcoholic fatty liver disease, chronic lung disease, solid organ transplantation, and prescribing in elderly are included, and human papilloma virus (HPV) vaccination recommendations have been expanded. All drug-drug interaction tables have been updated and new tables are included. Treatment options for direct-acting antivirals (DAAs) have been updated and include the latest combinations of sofosbuvir/velpatasvir/voxilaprevir and glecaprevir/pibrentasvir. Recommendations on management of DAA failure and acute HCV infection have been expanded. For treatment of tuberculosis (TB), it is underlined that intermittent treatment is contraindicated, and for resistant TB new data suggest that using a three-drug combination may be as effective as a five-drug regimen, and may reduce treatment duration from 18-24 to 6-10 months. CONCLUSIONS: Version 9.0 of the EACS Guidelines provides a holistic approach to HIV care and is translated into the six most commonly spoken languages. |
Issue Date: | 1-May-2018 |
Date of Acceptance: | 8-Jan-2018 |
URI: | http://hdl.handle.net/10044/1/73800 |
DOI: | https://doi.org/10.1111/hiv.12600 |
ISSN: | 1464-2662 |
Publisher: | Wiley |
Start Page: | 309 |
End Page: | 315 |
Journal / Book Title: | HIV Medicine |
Volume: | 19 |
Issue: | 5 |
Copyright Statement: | © 2018 The Authors. HIV Medicine Published by John Wiley & Sons Ltd on behalf of British HIV Association This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
Keywords: | ART European AIDS Clinical Society guidelines HBV HCV HIV antiretroviral treatment coinfections comorbidities opportunistic diseases AIDS-Related Opportunistic Infections Adult Anti-Retroviral Agents Antiretroviral Therapy, Highly Active Coinfection Drug Interactions Europe Female HIV Infections Humans Male Practice Guidelines as Topic Pregnancy Pregnancy Complications, Infectious Societies, Scientific EACS Governing Board Humans AIDS-Related Opportunistic Infections Pregnancy Complications, Infectious HIV Infections Anti-Retroviral Agents Antiretroviral Therapy, Highly Active Pregnancy Drug Interactions Adult Societies, Scientific Europe Female Male Practice Guidelines as Topic Coinfection ART European AIDS Clinical Society guidelines HBV HCV HIV antiretroviral treatment coinfections comorbidities opportunistic diseases AIDS-Related Opportunistic Infections Adult Anti-Retroviral Agents Antiretroviral Therapy, Highly Active Coinfection Drug Interactions Europe Female HIV Infections Humans Male Practice Guidelines as Topic Pregnancy Pregnancy Complications, Infectious Societies, Scientific Virology 1103 Clinical Sciences |
Publication Status: | Published |
Conference Place: | England |
Online Publication Date: | 2018-03-01 |
Appears in Collections: | Department of Infectious Diseases |